Transcranial Magnetic Stimulation in Clinical Psychiatry

Confirming the built-in sad obsolescence of books, the editors predict: ‘At the time of writing, oneTMS company has completed a large multisite (sic!) clinical trial of TMS in depression and has submitted the results to the U.S.Food and Drug Administration (FDA) for potential approval of treatment. Thus, it is likely that clinicians soon will have a new treatment tool, unlike virtually anything they are familiar with’